Ab De Novo Sequencing Market

The global Ab De Novo Sequencing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.

Monoclonal Antibodies Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Ab De Novo Sequencing include Nanjing Mingyan Biotechnology Co., Ltd., Suzhou Jinweizhi Biotechnology Co., Ltd., Beijing Baitai Parker Biotechnology Co., Ltd., Biocompare, Abveris, Rapid Novor, GenScript, Absolute Antibody and Curia Global, etc. in 2023, the global top five players have a share approximately % in terms of revenue.

Ab De Novo Sequencing Market aims to provide a comprehensive presentation of the global market for Ab De Novo Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ab De Novo Sequencing. Ab De Novo Sequencing Market contains market size and forecasts of Ab De Novo Sequencing in global, including the following market information:

Global Ab De Novo Sequencing Market Revenue, 2019-2024, 2025-2030, ($ millions)

Global top five companies in 2023 (%)

We surveyed the Ab De Novo Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ab De Novo Sequencing Market, by Type, 2019-2024, 2025-2030 ($ millions)

Global Ab De Novo Sequencing Market Segment Percentages, by Type, 2023 (%)

Monoclonal Antibodies

Polyclonal Antibodies

Global Ab De Novo Sequencing Market, by Application, 2019-2024, 2025-2030 ($ millions)

Global Ab De Novo Sequencing Market Segment Percentages, by Application, 2023 (%)

Academic and Research Institutions

Pharmaceutical and Biotech Companies

Diagnostic and Clinical Laboratories

Other

Global Ab De Novo Sequencing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)

Global Ab De Novo Sequencing Market Segment Percentages, By Region and Country, 2023 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ab De Novo Sequencing revenues in global market, 2019-2024 (estimated), ($ millions)

Key companies Ab De Novo Sequencing revenues share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

Nanjing Mingyan Biotechnology Co., Ltd.

Suzhou Jinweizhi Biotechnology Co., Ltd.

Beijing Baitai Parker Biotechnology Co., Ltd.

Biocompare

Abveris

Rapid Novor

GenScript

Absolute Antibody

Curia Global

ProteoGenix

CiteAb

BIOZOL

Outline of Major Chapters:

Chapter 1: Introduces the definition of Ab De Novo Sequencing, market overview.

Chapter 2: Global Ab De Novo Sequencing market size in revenue.

Chapter 3: Detailed analysis of Ab De Novo Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ab De Novo Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.